Stay updated on AAV9-GAA_IM in Late-Onset Pompe: Re-administration Clinical Trial
Sign up to get notified when there's something new on the AAV9-GAA_IM in Late-Onset Pompe: Re-administration Clinical Trial page.

Latest updates to the AAV9-GAA_IM in Late-Onset Pompe: Re-administration Clinical Trial page
- Check2 days agoChange DetectedThe record now presents details for a completed Phase 1 Pompe disease gene-therapy study, including its interventions, eligibility criteria, outcomes, and study dates. It also indicates the study enrolled 2 participants and is no longer recruiting.SummaryDifference82%

- Check9 days agoChange DetectedThe footer’s site revision label changed from v3.7.2 to v3.8.0; the study record still displays a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedA notice about NIH website updates and the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page.SummaryDifference1%

- Check23 days agoChange DetectedThe footer revision changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check29 days agoChange DetectedThe ClinicalTrials.gov footer revision indicator changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content with an access-denied screen. The visible elements include a Home button and a site footer, indicating the page is not displaying the expected study information.SummaryDifference23%

Stay in the know with updates to AAV9-GAA_IM in Late-Onset Pompe: Re-administration Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AAV9-GAA_IM in Late-Onset Pompe: Re-administration Clinical Trial page.